New hope for brain cancer? experimental combo targets glioblastoma
Disease control
Recruiting now
This early-stage study tests a new drug called RZ-001 combined with valganciclovir in people with glioblastoma, a serious brain cancer. The goal is to find a safe dose and see if the treatment can shrink tumors or help people live longer. About 43 adults with a specific tumor mar…
Phase: PHASE1, PHASE2 • Sponsor: Rznomics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:58 UTC